Search research articles
Contact Us
Filters
Showing results (181-190 of 201) with videos related to
Page
of 21
Sort By:
American Journal of Clinical Oncology
|
October 24, 2002
Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2)
David A Rinaldi, Nancy A Lormand, Joseph E Brierre, et al.
Psychiatry Research
|
December 20, 2000
Sex differences in response to red and blue light in human primary visual cortex: a bold fMRI study
R L Cowan, B B Frederick, M Rainey, et al.
Journal of General Internal Medicine
|
December 19, 2000
Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention
M O Rigsby, M I Rosen, J E Beauvais, et al.
Nature Communications
|
September 15, 2017
Perturbed cholesterol and vesicular trafficking associated with dengue blocking in Wolbachia-infected Aedes aegypti cells
Vincent Geoghegan, Kirsty Stainton, Stephanie M Rainey, et al.
Journal of Cancer Research & Therapy
|
June 20, 2017
<i>KRAS</i> testing and first-line treatment among patients diagnosed with metastatic colorectal cancer using population data from ten National Program of Cancer Registries in the United States
Adriana Rico, Lori A Pollack, Trevor D Thompson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2006
Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir
Elinore F McCance-Katz, David E Moody, Patrick F Smith, et al.
Plos Pathogens
|
April 19, 2016
Wolbachia Blocks Viral Genome Replication Early in Infection without a Transcriptional Response by the Endosymbiont or Host Small RNA Pathways
Stephanie M Rainey, Julien Martinez, Melanie McFarlane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2006
Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine
Elinore F McCance-Katz, David E Moody, Gene D Morse, et al.
Pediatrics
|
August 1, 1994
Screening for lead poisoning in an urban pediatric clinic using samples obtained by fingerstick
D J Schonfeld, M R Cullen, P M Rainey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 22, 2011
Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir
Valerie A Gruber, Petrie M Rainey, David E Moody, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 201) with videos related to
Sort By:
Page
of 21
American Journal of Clinical Oncology
|
October 24, 2002
Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2)
David A Rinaldi, Nancy A Lormand, Joseph E Brierre, et al.
Psychiatry Research
|
December 20, 2000
Sex differences in response to red and blue light in human primary visual cortex: a bold fMRI study
R L Cowan, B B Frederick, M Rainey, et al.
Journal of General Internal Medicine
|
December 19, 2000
Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention
M O Rigsby, M I Rosen, J E Beauvais, et al.
Nature Communications
|
September 15, 2017
Perturbed cholesterol and vesicular trafficking associated with dengue blocking in Wolbachia-infected Aedes aegypti cells
Vincent Geoghegan, Kirsty Stainton, Stephanie M Rainey, et al.
Journal of Cancer Research & Therapy
|
June 20, 2017
<i>KRAS</i> testing and first-line treatment among patients diagnosed with metastatic colorectal cancer using population data from ten National Program of Cancer Registries in the United States
Adriana Rico, Lori A Pollack, Trevor D Thompson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2006
Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir
Elinore F McCance-Katz, David E Moody, Patrick F Smith, et al.
Plos Pathogens
|
April 19, 2016
Wolbachia Blocks Viral Genome Replication Early in Infection without a Transcriptional Response by the Endosymbiont or Host Small RNA Pathways
Stephanie M Rainey, Julien Martinez, Melanie McFarlane, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 17, 2006
Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine
Elinore F McCance-Katz, David E Moody, Gene D Morse, et al.
Pediatrics
|
August 1, 1994
Screening for lead poisoning in an urban pediatric clinic using samples obtained by fingerstick
D J Schonfeld, M R Cullen, P M Rainey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 22, 2011
Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir
Valerie A Gruber, Petrie M Rainey, David E Moody, et al.
Page
of 21